The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 23, 2017

Filed:

Mar. 30, 2015
Applicant:

Hycor Biomedical, Inc., Indianapolis, IN (US);

Inventors:

Mark David Van Cleve, Long Beach, CA (US);

Elaine Grace Taine, Anaheim, CA (US);

Douglas John Canfield, Ludington, MI (US);

Stephanie TuVi Ortega, Santa Ana, CA (US);

Taylor Addison Reid, Carlsbad, CA (US);

Assignee:

Hycor Biomedical, LLC, Indianapolis, IN (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/564 (2006.01); G01N 35/10 (2006.01); G01N 21/64 (2006.01); G01N 33/543 (2006.01); G01N 33/68 (2006.01); G01N 33/53 (2006.01); G01N 33/58 (2006.01); G01N 35/00 (2006.01); G01N 21/76 (2006.01); G01N 33/569 (2006.01); G01N 35/04 (2006.01);
U.S. Cl.
CPC ...
G01N 33/564 (2013.01); G01N 21/645 (2013.01); G01N 21/6428 (2013.01); G01N 21/76 (2013.01); G01N 33/5306 (2013.01); G01N 33/54326 (2013.01); G01N 33/54393 (2013.01); G01N 33/569 (2013.01); G01N 33/582 (2013.01); G01N 33/6854 (2013.01); G01N 33/6893 (2013.01); G01N 35/0098 (2013.01); G01N 35/1011 (2013.01); G01N 2021/6484 (2013.01); G01N 2035/0453 (2013.01); G01N 2035/1062 (2013.01); G01N 2201/062 (2013.01); G01N 2201/08 (2013.01); G01N 2333/4703 (2013.01); G01N 2333/62 (2013.01); G01N 2333/78 (2013.01); G01N 2800/24 (2013.01); Y10T 436/119163 (2015.01);
Abstract

A quantitative method for diagnosing an autoimmune disease or an infectious disease comprising performing an automated diagnostic assay, comprising: incubating a capture reagent with a streptavidin-coated medium to form a solid phase complex, wherein the capture reagent is a biotinylated autoantigen or infectious disease antigen; washing the solid phase complex to remove excess capture reagent; incubating the solid phase complex with a serum sample to form an immune complex; washing the immune complex to remove any unbound sample; incubating the immune complex with a conjugate to create an immune-conjugate complex; washing the immune-conjugate complex to remove any unbound conjugate; introducing a substrate capable of generating a quantifiable response; and calibrating the response generated from introducing the substrate.


Find Patent Forward Citations

Loading…